calcium acetate has been researched along with Disease Exacerbation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muenz, LR; Qunibi, W | 1 |
| Evenepoel, P; Meijers, B | 1 |
| Nolan, CR; Qunibi, WY | 1 |
| Burke, S; Chasan-Taber, S; Chertow, GM; Ferramosca, E; Raggi, P; Ratti, C | 1 |
| Budoff, MJ; Gao, YL; Kessler, P; Mao, SS; Moustafa, M; Qunibi, W | 1 |
| Budoff, M; Diaz-Buxo, JA; He, DY; Kessler, PD; Moustafa, M; Muenz, LR; Qunibi, W | 1 |
1 review(s) available for calcium acetate and Disease Exacerbation
| Article | Year |
|---|---|
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis.
Topics: Acetates; Acid-Base Equilibrium; Calcinosis; Calcium Compounds; Coronary Vessels; Disease Progression; Dose-Response Relationship, Drug; Epoxy Compounds; Humans; Kidney Failure, Chronic; Phosphates; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; United States | 2005 |
2 trial(s) available for calcium acetate and Disease Exacerbation
| Article | Year |
|---|---|
The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study.
Topics: Acetates; Atorvastatin; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Prospective Studies; Pyrroles; Reproducibility of Results; Sevelamer; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
Topics: Acetates; Anticholesteremic Agents; Atorvastatin; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Female; Heptanoic Acids; Humans; Male; Middle Aged; Polyamines; Prospective Studies; Pyrroles; Renal Dialysis; Sevelamer; Time Factors | 2008 |
3 other study(ies) available for calcium acetate and Disease Exacerbation
| Article | Year |
|---|---|
Progression of calcification in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
Topics: Acetates; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Humans; Polyamines; Sevelamer | 2008 |
Chronic kidney disease: Phosphate binder therapy--cracks in the tower of strength?
Topics: Acetates; Blood Vessels; Calcinosis; Calcium Compounds; Chelating Agents; Disease Progression; Humans; Hyperphosphatemia; Lanthanum; Phosphate-Binding Proteins; Phosphates; Polyamines; Renal Insufficiency, Chronic; Sevelamer | 2012 |
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
Topics: Acetates; Aged; Anti-Inflammatory Agents; beta 2-Microglobulin; C-Reactive Protein; Calcium Compounds; Coronary Artery Disease; Disease Progression; Female; Fibrinolytic Agents; Homocysteine; Humans; Kidney Failure, Chronic; Lipoproteins; Male; Middle Aged; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer | 2005 |